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Woven Endobridge (WEB) Device as a Re-treatment Strategy after  




Surgical clipping of intracranial aneurysms is typically robust and durable. However, 
residual aneurysmal components may be seen after clipping.  Furthermore, there may be 
occasional aneurysmal recurrence. These are both clinically relevant because 
subarachnoid hemorrhage after clipping is a rare but important event. The rationale for 
any treatment is to substantially lower the future risk of hemorrhage. Small series have 
demonstrated coiling as a re-treatment strategy after unsuccessful clipping, but none have 
explored the feasibility of Woven Endobridge (WEB) implantation. 
CASE DESCRIPTION 
We examined the feasibility of WEB implantation as second-line treatment for wide-
necked residual aneurysms after unsuccessful clipping. We also recorded the safety and 
efficacy in this small series of 6 patients. To determine safety, we measured the modified 
Rankin Scale (mRS) before and after the procedure, and at two later time-points (mean 
follow-up 5 months and 15 months). To determine efficacy, we obtained radiographic 
aneurysm occlusion outcomes (including WEB Occlusion Scale) at these two time-points. 
Four middle cerebral artery and two anterior communicating artery complex aneurysms 
were treated with WEB implantation showing feasibility in 6/6 (100%) cases. Follow-up 
at 15 months demonstrated no change from pre-procedural mRS and there were no other 
complications. There was adequate occlusion in 5/6 (83%) cases.  
CONCLUSIONS 
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WEB implantation provided a feasible option in this challenging re-treatment scenario. 
We emphasize that this is a small series and prospective data is required to make outcome 
inferences for this population. Nonetheless, we observed no complications and high 





CT = computed tomography 
CTA = computed tomography angiography 
DSA = digital subtraction angiography 
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MRA = magnetic resonance angiography 
MRI = magnetic resonance imaging 
SL = single layer 
TOF = time-of-flight 
WEB = Woven Endobridge 
WFNS = world federation of neurosurgeons 





Surgical clipping of intracranial aneurysms is typically robust and durable,  however,  a 
residual aneurysmal component may be seen after clip placement in up to 4-8% of cases.1-
6 Furthermore, in 1-3% of cases there may be aneurysmal recurrence.5-7 These are both 
clinically relevant occurrences because there is a persistent risk of rupture or re-
rupture.3,5,8,9 Subarachnoid hemorrhage from remnants after surgical clipping is poorly 
quantified, but may occur in 0.8% of cases per annum.1-3 The rationale for any treatment 
is to substantially lower the future risk of hemorrhage and therefore re-treatment of 
residual or recurrent aneurysms is frequently indicated. A third scenario for re-treatment 
occurs when a clip cannot be placed safely and the surgeon judiciously elects to abandon 
the procedure.1 In all three scenarios, re-treatment with clipping appears to be associated 
with an increased rate of complications.1,10  Endovascular re-treatment appears to have a 
lower rate of complications, and has become more common in the last two decades.9 
However, many aneurysms that recur are wide-necked and are therefore challenging to 
treat by endovascular coiling alone because of the risk of coil protrusion into the parent 
vessel.11,12  A definitive re-treatment strategy has not been established and aneurysms are 
managed on a case-by-case basis. In this context, the Woven Endobridge (WEB; Sequent 
Medical, Çaliso Viejo, California) device might emerge as an endovascular re-treatment 
option in selected cases. Indeed, it has recently been shown in a small series that re-
treatment of recurrent, previously-coiled aneurysms with WEB implantation is feasible 
and may be safe and effective.13 The WEB is a nitinol, braided-mesh, self-expanding, 
intrasaccular flow-disrupter with a three-dimensional structure primarily designed to 
occlude wide-neck intracranial aneurysms. The second-generation WEB consists of a 
single layer compartment that impedes aneurysmal neck blood flow resulting in intra-
aneurysmal thrombosis and subsequent endothelialization. Since its introduction in 2011, 
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several single arm studies have shown that the WEB appears safe (low morbidity and 
mortality) and effective (high adequate occlusion rates) when used as a first-line implant 
to treat wide-neck ruptured and unruptured aneurysms.14-21 Whilst small series have 
demonstrated coiling as a re-treatment strategy after unsuccessful clipping,9 no series has 
explored the feasibility of WEB implantation. We describe the feasibility of WEB for re-
treatment of wide-neck aneurysms after surgical clipping has been unsuccessful. We 
report the combined experience of four centers and present safety (morbidity and 





Methods and materials 
We searched medical records for patients with residual aneurysms that were treated with 
WEB after unsuccessful surgical clipping between January 2014 and January 2016 at six 
UK hospitals. For each patient included in the study, we retrospectively analyzed the 
electronic medical records; pre-procedural, procedural and post-procedural images; as 
well as procedural records. We collected demographic, radiological and clinical data on 
an intention-to-treat basis. The presence of a residual aneurysm was confirmed on follow-
up digital subtraction angiography (DSA) and/or 3D time-of-flight MRA (3D TOF 
MRA). The diameter of any residual aneurysmal sac and neck were measured. 
  
WEB implantation for all cases was chosen following a consensus decision at a 
neurovascular multi-disciplinary team meeting which included interventional 
neuroradiologists and neurovascular surgeons. Anatomical characteristics (including 
location, a high neck-to-sac ratio and a wide neck), safety and technical concerns, and the 
role of anti-platelets, were the main factors leading to WEB implantation in preference to 
coiling, stent-assisted coiling or further clipping. 
 
Interventional neuroradiologists performed all procedures under general anesthesia using 
a femoral approach. Anticoagulation and anti-platelet therapies were administered 
according to local institutional protocol. 
 
To determine safety, we recorded the modified Rankin Scale (mRS) before and after the 
procedure and at follow-up at two later time points. Ischemic and hemorrhagic 
complications were analyzed. Imaging follow-up was performed with DSA (with 
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additional cone-beam CT angiography in some centers), or 3D time-of-flight (TOF) MRA 
(AERA 1.5 T, Siemens Healthcare GmbH, Germany) with TR 25 ms, TE 7 ms, flip angle 
25 (with ramped pulse), matrix 241 x 256, field of view 18 x 18 cm, and slice thickness 
1.4 mm (reconstructed to 0.5 mm). To determine efficacy, aneurysm occlusion status was 
classified using the WEB Occlusion Scale (WOS).22 Opacification of the WEB device 
recess (WOS 2) was considered complete occlusion. 
 
Written informed consent was obtained from all patients. We received written 
confirmation from the Research and Innovation Department at King’s College Hospital 
that the UK’s Health Research Authority does not require review by a Research Ethics 
Committee given the nature of the retrospective study using de-identified data. The study 
was performed in accordance with the ethical standards laid down in the 1964 Declaration 
of Helsinki and its later amendments.  
Results 
Six patients from four hospitals with residual bifurcation aneurysms after unsuccessful 
surgical clipping were re-treated with WEB implantation. The causes for unsuccessful 
surgical clipping were: the decision to abandon the procedure due to the presence of a 
mixed atheromatous and calcified plaque at the aneurysmal neck extending into the 
temporal M2 segment, which might cause emboli as well as temporal M2 segment 
occlusion if clipped (Patient 1; Figure 1); inability to create a dissection plane surrounding 
the aneurysm as it was adherent to the surrounding structures making clip placement 
technically challenging and unsafe (Patient 2); inability to safely dissect free the origins 
of the M2 branches which arose from the aneurysm neck increasing the risk of occluding 
an M2 branch (Patient 3). These three aneurysms were wrapped with muslin pending 
further re-treatment. Suboptimal clip placement resulted in inadvertent incomplete 
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clipping in Patients 4 (Figure 2), 5 (Figure 3), and 6 (Figure 4) despite indocyanine green 
angiography (ICGA) appearing to show satisfactory clip positioning. In patient 4 the 
procedure was complicated by impaired visualization of the neck branches and a bloody 
operative field. Baseline patient characteristics and initial aneurysm features are 
summarized in Table 1. 
 
The mean time between unsuccessful surgical intervention and re-treatment with WEB 
implantation was 37 days (range 2-90 days) (Table 2). A single WEB Single-Layer (SL) 
device was successfully implanted in all cases attempted. Pre-, intra-, and postoperative 
antiplatelet and anticoagulant therapy was managed in each center in accordance with the 
local institutional protocol at the time (Supplementary Table 1).  
 
There were no periprocedural thromboembolic or hemorrhagic complications (both 0%, 
0/6; Table 3). Periprocedural vasospasm was noted without clinical consequence in a 
single patient. The first and second clinical and radiographic follow-up time points were 
at 5 months (mean, range 3-6 months) and 15 months (range 8-24 months) after the 
procedure respectively. There was no change in the pre-procedural mRS in all 6 cases 
periprocedurally and at first and second follow-up time points. In particular, no patient 
died or became dependent (mRS 3-6) over the follow-up period. At the second follow-up 
time point, three patients had complete occlusion of the aneurysm (50%, 3/6; WOS 2), 
two patients had a neck remnant (33%, 2/6; WOS 3) and one patient a sac remnant (17%, 
1/6, WOS 4). The one patient with a sac remnant had a neck remnant at the first follow-
up (3 months) which subsequently became a sac remnant at second follow-up (8 months) 
at which point they underwent further re-treatment using coils and an Aneurysm Neck 
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Reconstruction Device (PulseRider, Pulsar Vascular, San Jose, California) in order to 
achieve complete occlusion.   
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Discussion 
Summary of findings 
We showed that WEB implantation was a feasible option in the challenging scenario 
where a wide-necked aneurysm or wide-necked aneurysmal component requires re-
treatment after unsuccessful surgical clipping. We observed that there were no 
complications and high adequate occlusion rates. 
Strengths and weaknesses  
To the best of our knowledge this is the first description of WEB re-treatment after 
unsuccessful surgical clipping.9 Small series case reports such as ours inevitably have 
inherent limitations and demonstrate feasibility only. Our series was retrospective and 
contained only a small number of patients. Data from a large prospective study is required 
to make outcome inferences for this population. However, it is challenging to obtain 
optimal data as shown in a recent systematic review of coiling re-treatment after clipping 
where the mean series size for studies was 8 (range 3-21) and all cases were 
retrospective.9 Furthermore, when stent coiling was assessed specifically, there were only 
five cases pooled from two series.9 Therefore, given the paucity of data regarding re-
treatment, our small series is likely to contribute to the interventional neuroradiology 
literature. A strength of our series is that four hospitals contributed cases. Furthermore, 
all endovascular cases from six hospitals with large neurovascular practices were 
reviewed for inclusion, which represented approximately 35% of UK practice (the total 
denominator of endovascular cases was two orders of magnitude more than the number 
of cases included in our series). Therefore, our cases are likely to be reasonably 
representative of current UK practice for this uncommon re-treatment strategy. Other 
limitations are that follow-up was relatively short (mean follow-up 5 months and 15 
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months) and 3D TOF MRA was used for follow-up in two cases. Whilst a recent meta-
analysis has shown that MRA (whether using TOF MRA or CEMRA) is a reliable 
modality for the follow-up of aneurysms treated using a variety of endovascular 
techniques (including stent-assisted coiling and flow diverters),23 it is possible that there 
was a reduction in sensitivity compared to DSA in detecting aneurysmal remnants 
according two small retrospective studies where WEB susceptibility was described.24,25 
It is conceivable that the adequate occlusion rates observed in our series could be lower. 
However, in most cases included in the two small retrospective studies, first-generation 
(double-layer) WEBs were used, MRA was performed at a higher field strength (3 T) and 
a different MRA technique was employed, all of which differed from the current series. 
Furthermore, in our two cases, other sequences (T1- and T2-weighted) and scan planes 
(multiplanar reformat) were reviewed and in all first treatment WEB implantations we 
have yet to discover a false negative remnant after a subsequent DSA. It is also 
noteworthy that cross-sectional MRI confirmed occlusion because a decrease in the size 
of the aneurysm sac on cross-sectional imaging appears to be the single most consistent 
sign of durable aneurysm occlusion (likely implying full endothelialization of the device 
construct and secondary exclusion of the aneurysm from the parent circulation).26,27  
Comparison with studies worldwide  
In our series, no thromboembolic or hemorrhagic complications occurred. As is inherent 
in small series case reports, statistical comparison cannot be made with other studies. 
Nonetheless, we observe that thromboembolic events (including asymptomatic ones) 
occurred in 14% of patients in the pooled results of three multicenter studies (WEBCAST, 
French Observatory, WEBCAST-2) investigating WEB for the primary treatment of 
unruptured aneurysms14 and in 8% of patients in a recent meta-analysis of 588 aneurysms 
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(127 ruptured) treated with WEB.16 In a recent series, 16 patients underwent re-treatment 
of recurrent, endovascularly-treated aneurysms with WEB implantation and there were 
thromboembolic events in 6%.13 
The morbidity and mortality rates were 1% and 0% respectively in the three multicenter 
studies combined;14 4% and 1% respectively in the meta-analysis of 588 aneurysms;16 
and 6% and 0% respectively in the re-treatment series.13  In our series, the outcomes were 
similar (both 0%). 
We evaluated aneurysm occlusion with the WOS, which has been used as a measurement 
scale in three large prospective multicenter WEB studies.14 Complete occlusion (WOS 
2), neck remnant (WOS 3), and aneurysm sac remnant (WOS 4) at follow-up imaging 
were observed in 50%, 33%, and 17% of all aneurysms respectively at a mean follow-up 
of 15 months. Owing to the small size of our sample, it was not possible to perform 
statistical analyses of aneurysm factors, such as the influence of the sac or neck size, or 
surgical factors (incomplete or no clip placed) that might influence occlusion status, but 
no association seemed apparent. Whilst re-iterating the limitations of comparison with 
other studies, we observe that the occlusion rates of our series appeared similar to the 
three multicenter studies combined in which complete occlusion, neck remnant, and sac 
remnant rates were 53%, 26%, and 21% at 12 months respectively.14 In the re-treatment 
series, the rates were 33%, 40% and 27% at 12 months. These occlusion rates also 
appeared similar to the recent meta-analysis of 588 aneurysms,16 where the adequate 
occlusion rate after a median of 7 months follow-up was 84% for unruptured and 85% 
for ruptured aneurysms, compared to 83% in our series.  
Study explanations and relevance from a national and international perspective  
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We have shown the feasibility of an additional re-treatment strategy after unsuccessful 
clipping by using WEB implantation. In some scenarios this may be preferable to 
clipping, coiling, or the use of stents with or without flow diverting properties.  
Anatomical or technical difficulties are likely to be the cause for unsuccessful clipping at 
the first treatment, making re-treatment with clipping intrinsically unfavourable.28 
Furthermore, adhesions surrounding the aneurysm, adjacent tissues or original clip may 
complicate re-treatment with clipping, particularly when there has been a lengthy interval 
between the surgeries.1,29 The morbidity and mortality rates are at least 7% (mRS score > 
2) and 5% respectively.1,3,10 Intraoperative rupture also appears to be more common 
during re-treatment.10 
 
The same disadvantages relating to coiling, stent-assisted coiling or flow diversion, that 
led the neurovascular multi-disciplinary team to recommend clipping at first treatment 
persisted when re-treatment was discussed. Anatomical characteristics including a high 
neck-to-sac ratio, a wide neck and being located at a bifurcation, limited the endovascular 
options which would typically require temporary balloon assistance as a minimum, or 
more often a stent (or two) to avoid coil protrusion into the parent vessel. Procedures 
using such adjuncts in wide neck bifurcations aneurysms can be technically complex and, 
compared to coiling alone, appear to have a higher periprocedural complication rate and 
a lower adequate occlusion rate, which at 6-18 months may be 63% or lower.30,31 
Furthermore, there is an increase in procedural time and radiation dose compared to 
standard coiling. Two aneurysms were also partially thrombosed (Patients 1 and 2); the 
implication of re-treatment with coiling (whether balloon or stent-assisted) is that there 
may be a higher rate of recanalization than in non-thrombosed cases.32 Flow diversion 
has been used rarely in bifurcation aneurysms and the long-term effects on covered 
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bifurcation branches and perforating arteries is not yet fully understood.33 Importantly, 
there are risks associated with prolonged dual anti-platelet use which is required after 
stent-assisted coiling or flow diversion. Following subarachnoid hemorrhage, the risk of 
periprocedural complications associated with dual anti-platelet use is particularly high.34 
An additional disadvantage of coiling that occurs after clipping is that treatment appears 
to be more technically challenging, possibly due to perianeurysmal scarring increasing 
the aneurysm wall rigidity.35  
At the time when this series was performed, the neurovascular multi-disciplinary team 
had recommended clipping as first treatment, and not WEB implantation, because there 
was insufficient outcome data for WEB implantation of wide-necked bifurcation 
aneurysms compared to clipping (Patients 1-4) (neither WEBCAST, WEBCAST 2 or 
French Observatory studies had been published14 nor had UK NICE guidelines been 
published approving routine first line use of WEB36). After unsuccessful clipping, 
because the disadvantages of performing coiling, stent-assisted coiling or flow diversion 
persisted and because re-treatment with clipping became high risk, a cost-benefit analysis 
by the neurovascular multi-disciplinary team favored WEB implantation as a re-treatment 
strategy. In two patients WEB implantation at first treatment was less suitable due to the 
aneurysm morphology (Patient 5; Figure 3) or entirely unsuitable due to size (Patient 6; 
Figure 4) so this option was never considered by the neurovascular multi-disciplinary 
team initially. However, after clipping the remodeled aneurysm inadvertently allowed re-
treatment with WEB implantation.  
In the two cases where there was partially thrombosed aneurysm (Patients 1 and 2), the 
proximal component of the aneurysm was not thrombosed and the size and morphology 
were suitable for WEB “corking” of this proximal component (Figure 1).37 At 6 and 18 
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months, there was adequate occlusion in these two aneurysms. Therefore, we have also 
shown in this series that WEB “corking” of the proximal component of an aneurysm 
which is partially thrombosed is a feasible treatment option. It is noteworthy that the 
selective targeting of the proximal component does not contradict a report which showed 
that WEB is a suboptimal treatment for thrombosed aneurysm sacs in general.38 
CONCLUSIONS 
We showed that WEB implantation was a feasible option in the challenging scenario 
where a wide-necked aneurysm or wide-necked aneurysmal component requires re-
treatment after unsuccessful surgical clipping. We observed that in our series the 
implantation was safe (no morbidity and mortality) and effective (high adequate 
occlusion rates). Technical, radiological and clinical outcomes for this indication appear 
similar to studies where WEB implantation was used as the primary treatment of 
aneurysms. We highlight that despite the increasing evidence from prospective 
studies, not all neurovascular multi-disciplinary teams agree that WEB implantation 
should be used even for first line treatment.39-41 We emphasize that this is a small series 
and prospective data from a larger cohort with longer follow-up would be optimal to 
generate higher level evidence and outcome inferences for this population. If future 
higher level evidence shows outcomes to be similar to our observations, potential 
indications for re-treatment with WEB implantation might resemble the indications 
for re-treatment after coiling:13 (1) bifurcation aneurysm; (2) aneurysm or aneurysmal 
component after clipping; (3) and configuration suitable for WEB implantation. 
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Figure 1. Panel of images showing an aneurysm that was re-treated with WEB 
implantation following an unsuccessful attempt at surgical clipping (Patient 1). A 
patient in their 50s presented with a single seizure. They were hypertensive, had chronic 
obstructive pulmonary disease and had a 40-pack year smoke history. A left MCA 
bifurcation aneurysm was discovered on MRI and characterization with CTA showed a 
partially thrombosed, 21 mm (maximal diameter) aneurysm with a 5 mm wide neck (A, 
B). The decision of the neurovascular multidisciplinary team (MDT) and patient was for 
surgical clipping. A mixed atheromatous and calcified plaque at the aneurysmal neck 
extending into the temporal M2 segment was seen at surgery (C) prevented a safe clipping 
due to the risk of emboli and the risk of occlusion of the temporal M2 segment. Muslin 
wrapping was performed instead. The aneurysm was unchanged on DSA, and after MDT 
and patient discussion, underwent WEB implantation 3 months later. A 6 Fr Shuttle 
catheter (Cook Medical, Indiana, USA), a 0.072” Navien intracranial support catheter 
(Medtronic, Dublin, Ireland) and a 0.027” Via microcatheter (Microvention, Tustin, 
USA) were used to deploy a single layer 6 mm (width) x 4 mm (height) WEB SL device 
into the neck of the aneurysm as a cork (D). Adjunctive coils were placed into the distal 
sac (D) through a 1.7 Fr Echelon-10 microcatheter (Medtronic, Dublin, Ireland). Aspirin 
75 mg PO OD was given before, during and after all procedures (prescribed 
independently for cardiovascular risk). Heparin was given at the beginning (5000 IU IV), 
end  (3000 IU IV) and following the procedure (1000 IU/h IV over 20 h). Complete 
occlusion of the aneurysm was shown at the end of the procedure with normal filling of 
the left MCA circulation. There were no complications periprocedurally or during 18-





Figure 2. Panel of images showing an aneurysm that was re-treated with WEB 
implantation following incomplete surgical clipping (Patient 4). A patient in their 50s 
was referred for treatment after incidental discovery of a right MCA bifurcation 
aneurysm. The patient was hypertensive and a smoker. Cone-beam CT angiography 
(DynaCTA) showed a 8 mm (maximal diameter) aneurysm with a 6 mm wide neck (A). 
The decision of the MDT and patient was for surgical clipping. The procedure was 
complicated by difficulty of clip placement due to impaired visualization of neck M2 
branches and a bloody operative field. Intra-operative fluorescence angiography 
demonstrated that neck coverage, whilst incomplete, gave adequate occlusion. The 
patient developed an ischemic infarct within the operated territory. (B) Follow-up DSA 
showed that the aneurysm remained almost identical. The case was reassessed in the MDT 
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and after discussion with the patient, WEB implantation was planned 2 months after 
clipping. A 6 Fr Envoy catheter (Codman, Raynham, USA), a 0.058” Navien intracranial 
support catheter (Medtronic, Dublin, Ireland) and a 0.027” Via microcatheter 
(Microvention, Tustin, USA) were used to deploy a single layer 7 mm (width) x 5 mm 
(height) WEB SL device (C). The patient was commenced on aspirin 150 mg PO OD and 
clopidogrel 150 mg PO OD 3 days before the procedure. 5000 IU heparin IV was given 
at the beginning of the procedure. Complete occlusion of the aneurysm was shown at the 
end of the procedure with normal filling of the right MCA circulation (C). There were no 
new complications periprocedurally or during 24-month follow-up. Six and 24 month 




Figure 3. Panel of images showing an aneurysm whose morphology changed after 
incomplete surgical clipping allowing  re-treatment with WEB implantation (Patient 
5). 
A patient in their 50s presented with a WFNS grade 1 subarachnoid hemorrhage due to a 
ruptured 9 mm (maximal diameter) right MCA bifurcation aneurysm with a 5 mm neck, 
shown here on an CTA reformat (A). The decision of the MDT and patient was for 
surgical clipping. Surgery was performed using intra-operative fluorescence angiography 
and the clipping was uneventful. (B) However, at 2 month DSA follow-up there was a 4 
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mm (maximal diameter) aneurysm remnant with a 4 mm wide neck, shown here as an 
unsubtracted image where the morphology was now more suitable for WEB implantation. 
The case was reassessed in the MDT and after discussion with the patient, WEB 
implantation was performed. A 6 Fr Benchmark catheter (Penumbra, Alameda, USA) and 
a 0.021” Via microcatheter (Microvention, Tustin, USA) was used to deploy a single 
layer 5 mm (width) x 3 mm (height) WEB SL device (C). The patient was commenced 
on aspirin 300 mg aspirin and clopidogrel 300 mg the evening before and the morning of 
the procedure. 5000 IU heparin IV was given at the beginning of the procedure. (D) 
Adequate occlusion of the aneurysm was shown at the end of the procedure with normal 
filling of the right MCA circulation. There were no new complications periprocedurally 
or during 24-month follow-up. Six and 8 month DSA confirmed persisting adequate 
occlusion. 
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Figure 4. Panel of images showing an aneurysm whose size changed after incomplete 
surgical clipping allowing  re-treatment with WEB implantation (Patient 6). 
A patient in their 60s presented with a WFNS grade 1 subarachnoid hemorrhage due to a 
ruptured 11 (maximal diameter) anterior communicating artery complex bifurcation 
aneurysm with an 8 mm neck, shown here on an CTA reformat (A). The decision of the 
MDT and patient was for surgical clipping. Surgery was performed using intra-operative 
fluorescence angiography and the clipping was uneventful. (B) However, at 7 day DSA 
follow-up there was a 4 mm (maximal diameter) aneurysm remnant (arrow) with a 4 mm 
wide neck, shown here as a cone-beam CT angiography reformat (clip is purple). The 
aneurysm morphology was now suitable for WEB implantation. The case was reassessed 
in the MDT and after discussion with the patient, WEB implantation was performed the 
same day. A 6 Fr Benchmark catheter (Penumbra, Alameda, USA) and a 0.021” Via 
microcatheter (Microvention, Tustin, USA) was used to deploy a single layer 5 mm 
(width) x 3 mm (height) WEB SL device (C). 5000 IU heparin IV was given at the 
beginning of the procedure and 500 mg aspirin IV was given after WEB implantation. 
Aspirin 75 mg PO OD was given after the procedure for 6 weeks. Complete occlusion of 
the aneurysm was shown at the end of the procedure with normal filling of the right MCA 
circulation. There were no new complications periprocedurally or during 16-month 
follow-up. Three and 6 month DSA confirmed persisting complete occlusion (D) 






Table 1: Baseline patient characteristics and pre-clipping aneurysm features  
 Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 










COPD    Breast 
cancer 
 

























21 15 9 8 9 11 
Neck width 
(mm) 
5 9 6 6 5 8 
Ruptured 
aneurysm 
No No Yes No Yes Yes 
Thrombosed 
aneurysm 
Yes Yes No No No No 
HTN: arterial hypertension; COPD: chronic obstructive pulmonary disease; mRS: modified Rankin Scale; 
SAH: subarachnoid hemorrhage; MCA: middle cerebral artery; Acomm: anterior communicating artery. 
 * Decades given rather than specific age; and individual sex not given, in order to maintain the highest 








Table 2: Time between the first clipping treatment and WEB implantation re-treatment; and pre-













Time from clip treatment to 
WEB re-treatment (days) 
90 2 2 60 60 7 
Post-clipping mRS 0 0 1 2 0 0 
Maximal sac diameter 
(mm) 
21 15 9 8 4 4 
Neck width (mm) 5 9 6 6 4 4 
Thrombosed aneurysm Yes Yes No No No No 
mRS: modified Rankin Scale 
 
 
Table 3: Periprocedural complications and follow-up  
 Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 
Periprocedural 
complications 
No No No No No No 
Brain ischemia No No No No No No 








































(WOS 2)   (WOS 2)  (WOS 2) 
Follow-up 
mRS  
0 at 6 & 18 
months 
0 at 6 & 18 
months 
1 at 3 & 8 
months 
2 at 6 & 24 
months 
0 at 6 & 8 
months 





























(WOS 2)  














(WOS 2)  
at 3 & 16 
months DSA 
WEB Occlusion Scale (WOS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
